BIOS Fund I, LP is 10% Owner at Lantern Pharma Inc. (LTRN). They have made 4 open-market trades across 2 companies since 2022, most recently 2025-06-12.
CIK 0001697316
1 open-market purchase totalling $175K since 2022, against 3 sales. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.